Dr. Camille Dauvergne

Dr. Camille Dauvergne is a researcher in the Epidemiology and Public Health Impact Unit at the International Vaccine Institute in Seoul, South Korea. Her current research focuses on antimicrobial resistance (AMR) in Southeast Asia, capacity-building projects for research preparedness and regulatory support worldwide, and vaccine effectiveness studies for cholera and malaria in Africa.

Dr. Dauvergne holds a Doctorate in Pharmacy from Paris-Saclay University and an M.Sc. in International Health Policy from the London School of Economics and Political Science. With extensive experience in clinical settings, government agencies, the European Medicines Agency, and international organizations, she has contributed to a number of health initiatives spanning product development and policy advocacy.